Investing Profile

Paul Conley

InvestorVC
Managing Director at Paladin Capital Group
Photo of Paul Conley, Managing Director at Paladin Capital Group

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Paladin Capital Group Managing Director
$100K - $5.0M
$1.5M
28
$372M
CompanyStageDateRound SizeTotal Raised
Aralez Bio
Series AOct 2024$12M
$12M
Co-investors: Maureen Boyce (Good Growth Capital)
Constructive Bio
Series ASep 2024$58M
$73M
Co-investors: Shyam Kamadolli (Fine Structure Ventures), Pierre Socha (Amadeus Capital Partners), Jonathan Milner
Alida Biosciences
Series AJun 2024$8M
SeedMay 2022$4M
Pre SeedJul 2021$510K
$13M
Infinimmune
SeedDec 2022$12M
$12M
Co-investors: Jory Bell (Playground Global), Stephen Cole
Menlo Micro
Series CMar 2022$150M
Series BOct 2020$44M
Series ADec 2016$34M
$230M
Co-investors: Tony Fadell (Future Shape), Marc van den Berg (OGCI Climate Investments (CI)), Marianne Wu (GE Ventures), Bennett Cohen (Piva Capital), Ira Ehrenpreis (DBL Partners), Bradley Horowitz
ONI
Series BDec 2021$75M
$75M
Co-investors: Mike Pellini (Section 32), Keith Crandell (ARCH Venture Partners), Vasudev Bailey (Artis Ventures (AV)), David Schwab (Vertical Venture Partners)
NanoCellect Biomedical
Series DAug 2021$20M
Series CFeb 2021$15M
$45M
Co-investors: Alexis Yongmei Ji (Illumina Ventures), Jenny Rooke (Genoa Ventures)
Edifice Health
Series AApr 2021$12M
$12M
Co-investors: Naveen Krishnan (Leaps by Bayer)
Founder / CEO General Inception2020 - Present
Partner Vertical Venture Partners2015 - Present